Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Mucosal Immunology|December 4, 2009
Cycling of gut mucosal CD4+ T cells decreases after prolonged anti-retroviral therapy and is associated with plasma LPS levelsE J Ciccone, S W Read, P J Mannon, et al.HIV Clinical Trials|August 9, 2013
Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infectionK J Cortez, M A Proschan, L Barrett, et al.Psychosomatic Medicine|March 10, 1998
Reproducibility of mental stress-induced myocardial ischemia in the Psychophysiological Investigations of Myocardial Ischemia (PIMI)R M Carney, R P McMahon, K E Freedland, et al.Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|July 25, 1998
Rapid early action for coronary treatment: rationale, design, and baseline characteristics. REACT Research GroupD G Simons-Morton, D C Goff, S Osganian, et al.The American Journal of Clinical Nutrition|July 14, 2001
Effects on blood lipids of a blood pressure-lowering diet: the Dietary Approaches to Stop Hypertension (DASH) TrialE Obarzanek, F M Sacks, W M Vollmer, et al.JAMA|June 29, 2000
Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) TrialR V Luepker, J M Raczynski, S Osganian, et al.Journal of the American Dietetic Association|August 18, 1999
The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research GroupL P Svetkey, F M Sacks, E Obarzanek, et al.Proceedings of the National Academy of Sciences of the United States of America|May 28, 2009
Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapyJ B Dinoso, S Y Kim, A M Wiegand, et al.Pageof 4